Mebucaïne Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle

7680690440015 CH-69044 Spray zur Anwendung in der Mundhöhle
Mebucaïne Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle
Mebucaïne Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle
Mebucaïne Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle
1 / 3
google

Article details

Package size
15
Selling units
15
Measure
ml
Galenic form
Spray zur Anwendung in der Mundhöhle
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/01/2025
Patient information leaflet
Français
22/01/2025
Patient information leaflet
Italien
22/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
17.16 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.59 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69044
Drug name
Mebucaïne Dolo Spray, Spray zur Anwendung in der Mundhöhle
Galenic form
SPRL
ATC Code
R02AX01
Authorization status
Z
Dispensing category
D
First authorization
13/09/2023
Authorization expiration date
12/09/2028
IT Number
12.03.2.
Domain
Human medicine
Field of application
Kurzzeitige symptomatische Behandlung schmerzhafter Entzündungen der Rachenschleimhaut

Package details

Description (FR)
MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml
Description (DE)
MEBUCAÏNE Dolo Spray 8.75 mg Fl 15 ml
Market launch
13/09/2023
Narcotic (BTM)
No